Compare MCS & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCS | QDEL |
|---|---|---|
| Founded | 1935 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 853.4M | 989.5M |
| IPO Year | 1994 | 2022 |
| Metric | MCS | QDEL |
|---|---|---|
| Price | $28.10 | $10.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $23.33 | ★ $28.25 |
| AVG Volume (30 Days) | 174.1K | ★ 1.2M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 0.77 | N/A |
| Revenue | $758,458,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $12.05 | $3.51 |
| Revenue Next Year | $3.15 | $3.86 |
| P/E Ratio | $36.70 | ★ N/A |
| Revenue Growth | ★ 3.11 | N/A |
| 52 Week Low | $12.85 | $9.92 |
| 52 Week High | $32.42 | $35.58 |
| Indicator | MCS | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 36.03 |
| Support Level | $26.52 | $9.92 |
| Resistance Level | $31.15 | $12.85 |
| Average True Range (ATR) | 0.63 | 0.64 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 91.81 | 14.56 |
Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.